Clinical Professor of Internal Medicine
Program Director, Fellowship - Infectious Diseases
Medical School
[email protected]
Available to mentor
Daniel R Kaul
Clinical Professor
-
Callegari M, Danziger-Isakov LA, Rose A, Kaul D, Shaffer K, Chong PP, Florescu D, German K, Avery R, Nguyen MH, Wildfeuer B, Michaels MG, Green M, Guo K, Zhao L, Daud A, Ison MG. Transplant Infectious Disease, 2024 Jun 1; 26 (3):Journal ArticlePresentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study
DOI:10.1111/tid.14270 PMID: 38526183 -
Gondi KT, Kaul DR, Gregg KS, Golbus JR, Aaronson KD, Murthy VL, Konerman MC. Journal of Heart and Lung Transplantation, 2024 Mar 1; 43 (3): 432 - 441.Journal ArticleCytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation
DOI:10.1016/j.healun.2023.10.005 PMID: 37813130 -
Rao K, Zhao Q, Bell J, Krishnan J, Henig O, Daniel J, Sawaya K, Albin O, Mills JP, Petty LA, Gregg K, Kaul D, Malani AN, Pogue J, Kaye KS. Clinical Infectious Diseases, 2024 Oct 11; 78 (2): 277 - 282.Journal ArticleAn Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections
DOI:10.1093/cid/ciad606 -
Wortham JM, Haddad MB, Stewart RJ, Annambhotla P, Basavaraju SV, Nabity SA, Griffin IS, McDonald E, Beshearse EM, Grossman MK, Schildknecht KR, Calvet HM, Keh CE, Percak JM, Coloma M, Shaw T, Davidson PJ, Smith SR, Dickson RP, Kaul DR, Gonzalez AR, Rai S, Rodriguez G, Morris S, Armitige LY, Stapleton J, Lacassagne M, Young LR, Ariail K, Behm H, Jordan HT, Spencer M, Nilsen DM, Denison BM, Burgos M, Leonard JM, Cortes E, Thacker TC, Lehman KA, Langer AJ, Cowan LS, Starks AM, LoBue PA. Morbidity and Mortality Weekly Report, 2024 Jan 5; 72 (52-53): 1385 - 1389.Journal ArticleSecond Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023
DOI:10.15585/mmwr.mm725253a1 PMID: 38175804 -
Ichimaru N, Natori Y, Alloway RR, Wojciechowski D, Castillo Almeida NE, Futamura K, Watanabe T, Nakagawa K, Egawa H, Parajuli S, Alhamad T, Mour G, Young JAH, Kaul D, Mallavarapu R, Garner B, Faravardeh A, Rajagopal A, Majeed A, Watarai Y, Kenmochi T, Iwami D, Kobayashi T, Kishikawa H, Yokoyama N, Muramatsu M, Nonomura N, Takagi T, Okabe Y, Morishima A, Yamanaga S, Iwamoto H, Takao T, Ota M, Uchida J, Shinoda K. Transplantation, 2024 Jan 1;Journal ArticlePhase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)
DOI:10.1097/TP.0000000000005260 PMID: 40072882 -
El Chaer F, Kaul DR, Englund JA, Boeckh M, Batista MV, Seo SK, Carpenter PA, Navarro D, Hirsch HH, Ison MG, Papanicolaou GA, Chemaly RF. Transplantation and Cellular Therapy, 2023 Dec 1; 29 (12): 730 - 738.Journal ArticleAmerican Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
DOI:10.1016/j.jtct.2023.09.018 PMID: 37783338 -
Boutin C-A, Callegari MA, Florescu DF, Nguyen M-H, Kaul D, Avery RK, Chong PP, Fisher CE, Limaye A, Clough LA, Pergam SA, Green MD, Michaels MG, Danziger-Isakov LA, Angarone MP, Keefer L, Daud A, Ison M. Open Forum Infectious Diseases, 2023 Nov 28; 10 (Supplement_2): ofad500.965Journal Article920. A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
DOI:10.1093/ofid/ofad500.965 PMID: PMC10677881 -
Inagaki K. Transplantation, 2023 Feb 15;Journal ArticleRisk of Staphylococcus aureus Bacteremia Before and After Solid Organ Transplantation
